Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
635 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,688 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (367)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04065152 | Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma(KAPVEC) | unknown | Phase 2 | 20 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT04867421 | Neutrophils in Bone Sarcomas(TANOs) | unknown | — | 25 | Université de Reims Champagne-ArdenneOTHER | 1 | May 25, 2022 |
| clinicaltrials |
| NCT04856306 | Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L(Magical) | unknown | — | 300 | Medstar Health Research InstituteOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT02013336 | Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors | unknown | Phase 1 | 30 | South Plains Oncology ConsortiumNETWORK | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04825470 | Liver Transplantation for Unresectable GIST Liver Metastases(TRANSGIST) | unknown | N/A | 50 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05272358 | Economic Evaluation of Sarcoma Patients Management in France(OPTISARC) | unknown | — | 2,431 | Centre Leon BerardOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT05142631 | Fruquintinib in the Treatment of Soft Tissue Sarcoma | unknown | Phase 2 | 31 | Fudan UniversityOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05121350 | A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma | unknown | Phase 3 | 256 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Feb 18, 2022 | clinicaltrials |
| NCT02630368 | A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)(METROmaJX) | unknown | Phase 1 / Phase 2 | 197 | Institut BergoniéOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT05194605 | Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma | unknown | — | 800 | West China HospitalOTHER | 1 | Jan 31, 2022 | clinicaltrials |
| NCT05204524 | Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma | unknown | N/A | 28 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT05179850 | Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children | unknown | — | 400 | West China HospitalOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05193214 | A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma | unknown | Phase 2 | 30 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.INDUSTRY | 1 | Jan 14, 2022 | clinicaltrials |
| NCT05171413 | Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma | unknown | — | 800 | West China HospitalOTHER | 1 | Dec 28, 2021 | clinicaltrials |
| NCT05138146 | A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma | unknown | Phase 2 | 70 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.INDUSTRY | 1 | Nov 30, 2021 | clinicaltrials |
| NCT04945512 | Efficacy of Epidural Analgesia in Lower Extremity Osteosarcoma | unknown | N/A | 28 | Istanbul UniversityOTHER | 1 | Nov 9, 2021 | clinicaltrials |
| NCT00954174 | Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer | unknown | Phase 3 | 637 | GOG FoundationNETWORK | 2 | Sep 30, 2021 | clinicaltrials |
| NCT04935333 | Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy(MYOSARCII) | unknown | — | 600 | IgenomixINDUSTRY | 1 | Sep 10, 2021 | clinicaltrials |
| NCT03298971 | The Impact of Cancer on the Physical and Psychosocial Well-being Among Childhood Osteosarcoma Survivors | unknown | — | 240 | The University of Hong KongOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04214457 | Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas(MYOSARC) | unknown | — | 1,000 | IgenomixINDUSTRY | 1 | Sep 5, 2021 | clinicaltrials |
| NCT04757064 | Efficacy of Exercise Program on Osteosarcoma Patients | unknown | N/A | 40 | Cairo UniversityOTHER | 0 | Aug 6, 2021 | clinicaltrials |
| NCT04519593 | ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma | unknown | N/A | 120 | Mother and Child Clinic Saint-PetersburgOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT04619030 | Augmented Reality (AR): The Future of "Patient Information Leaflets | unknown | N/A | 20 | NHS Greater Glasgow and ClydeOTHER | 1 | Jun 10, 2021 | clinicaltrials |
| NCT04910126 | Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma | unknown | Phase 2 | 84 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04556669 | Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors | unknown | Phase 1 | 30 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | May 27, 2021 | clinicaltrials |
| NCT04628806 | Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells(HSP70CTC) | unknown | — | 120 | Charite University, Berlin, GermanyOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT04886765 | A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma | unknown | Phase 1 / Phase 2 | 238 | AlaMab Therapeutics (Shanghai) Inc.INDUSTRY | 0 | May 14, 2021 | clinicaltrials |
| NCT04864821 | Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor | unknown | Early Phase 1 | 24 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 0 | May 6, 2021 | clinicaltrials |
| NCT04400942 | Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy | unknown | — | 600 | Ospedale Policlinico San MartinoOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT03623581 | Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226) | unknown | Phase 2 | 35 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Mar 3, 2021 | clinicaltrials |
| NCT04765228 | Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma | unknown | Phase 2 | 45 | Yong ChenOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04748978 | OPPIuM Technique and Myolysis With Diode Laser Dwls(Myolysis) | unknown | N/A | 35 | University of CagliariOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT03989596 | Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas(SINDIR) | unknown | Phase 2 | 30 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 1, 2021 | clinicaltrials |
| NCT04637022 | 4K Versus 3D Laparoscopic Colporraphy by Surgeons in Training: a Prospective Randomized Trial | unknown | — | 50 | Catholic University of the Sacred HeartOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT03651375 | Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall(UN-RESARC) | unknown | Phase 2 | 46 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT04659733 | Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children | unknown | Phase 1 | 36 | Yizhuo ZhangOTHER | 0 | Dec 9, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04606108 | Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma | unknown | Phase 2 | 62 | Sun Yat-sen UniversityOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT04518488 | Prehabilitation Soft-Tissue Sarcoma of Lower Limb | unknown | N/A | 30 | McGill UniversityOTHER | 0 | Sep 21, 2020 | clinicaltrials |
| NCT04517019 | Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy(OnkoFit II) | unknown | N/A | 201 | University Hospital TuebingenOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04356872 | The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma | unknown | Phase 2 | 45 | Fudan UniversityOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT04461223 | Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR | unknown | — | 55 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 8, 2020 | clinicaltrials |
| NCT04447274 | A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS | unknown | Phase 2 | 20 | Chinese Academy of Medical SciencesOTHER | 0 | Jun 25, 2020 | clinicaltrials |
| NCT04191603 | TWO DİFFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY | unknown | N/A | 100 | Alkü Alanya Education and Research HospitalOTHER | 1 | Jun 23, 2020 | clinicaltrials |
| NCT04192643 | INTERVENTION WITH TRANEXAMIC ACID TO REDUCE HAEMORRHAGE DURING LAPAROSCOPIC MYOMECTOMY | unknown | N/A | 60 | Alkü Alanya Education and Research HospitalOTHER | 1 | Jun 23, 2020 | clinicaltrials |
| NCT04192812 | PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS | unknown | N/A | 100 | Alkü Alanya Education and Research HospitalOTHER | 1 | Jun 23, 2020 | clinicaltrials |
| NCT04426760 | Fibroids and Infertility - a Study of the Significance of Removal of Fibroids With Regard to Endometrial Receptivity(FIN) | unknown | — | 80 | Oslo University HospitalOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT02968303 | Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy(COWBOY) | unknown | Phase 2 | 200 | Radboud University Medical CenterOTHER | 1 | Jun 5, 2020 | clinicaltrials |
| NCT04351308 | Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma(MAPAC) | unknown | Phase 2 | 60 | Peking University People's HospitalOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT04295109 | Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function | unknown | N/A | 105 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 24, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Jun 10, 2022source: clinicaltrials